Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit

被引:101
作者
Jones, Jeffrey C.
Rogers, Theodore J.
Brookmeyer, Peter
Dunne, William Michael, Jr.
Storch, Gregory A.
Coopersmith, Craig M.
Fraser, Victoria J.
Warren, David K.
机构
[1] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Surg & Anesthesiol, St Louis, MO 63110 USA
关键词
D O I
10.1086/520663
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) can be a precursor to serious infection, and decolonization with topical mupirocin has been studied as a means of preventing clinical infection. Mupirocin resistance in patients with MRSA has been reported, usually in the context of widespread mupirocin use. Methods. Patients admitted to a surgical intensive care unit ( SICU) had nasal swab cultures for MRSA performed at admission, weekly, and at discharge in an active surveillance program. Collected MRSA isolates were tested for mupirocin resistance, and molecular analysis was performed. Clinical data on the characteristics and outcomes of the patients who stayed in the SICU for > 48 h were collected prospectively. Results. Of the 302 MRSA isolates available for testing, 13.2% were resistant to mupirocin, with 8.6% having high-level resistance ( minimum inhibitory concentration, >= 512 mu g/mL) and 4.6% having low-level resistance ( minimum inhibitory concentration, 8-256 mu g/mL). Patients admitted to the SICU for > 48 h who were colonized with mupirocin-resistant MRSA were more likely to have been admitted to our hospital during the previous year (P = .016), were older (P = .009), and had higher in-hospital mortality (16% vs. 33%; P = .027), compared with patients colonized with mupirocin-susceptible MRSA. Molecular analysis of the mupirocin-resistant isolates revealed that 72.5% of isolates contained staphylococcal cassette chromosome mec II. Repetitive sequence polymerase chain reaction typing revealed that high-level mupirocin resistance was present in multiple clonal groups. The rate of mupirocin use hospital-wide during the study period was 6.08 treatment-days per 1000 patient-days. Conclusions. We documented a high rate of mupirocin resistance in MRSA isolates from SICU patients, despite low levels of in-hospital mupirocin use.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 29 条
[1]   Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin [J].
Bastos, MCF ;
Mondino, PJJ ;
Azevedo, MLB ;
Santos, KRN ;
Giambiagi-deMarval, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (06) :393-398
[2]  
BOELAERT JR, 1993, NEPHROL DIAL TRANSPL, V8, P235
[3]   The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice [J].
Cookson, BD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :11-18
[4]   Molecular evidence that nasal carriage of Staphylococcus aureus plays a role in respiratory tract infections of critically Ill patients [J].
Corne, P ;
Marchandin, HN ;
Jonquet, O ;
Campos, J ;
Bañuls, AL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) :3491-3493
[5]   MOLECULAR GENOTYPING OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS VIA FLUOROPHORE-ENHANCED REPETITIVE-SEQUENCE PCR [J].
DELVECCHIO, VG ;
PETROZIELLO, JM ;
GRESS, MJ ;
MCCLESKEY, FK ;
MELCHER, GP ;
CROUCH, HK ;
LUPSKI, JR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (08) :2141-2144
[6]   Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods [J].
Deshpande, LM ;
Fix, AM ;
Pfaller, MA ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 42 (04) :283-290
[7]   Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay [J].
Francois, P ;
Pittet, D ;
Bento, M ;
Pepey, B ;
Vaudaux, P ;
Lew, D ;
Schrenzel, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :254-260
[8]   Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus [J].
Harbarth, S ;
Dharan, S ;
Liassine, N ;
Herrault, P ;
Auckenthaler, R ;
Pittet, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1412-1416
[9]   MOLECULAR CHARACTERIZATION OF THE GENE ENCODING HIGH-LEVEL MUPIROCIN RESISTANCE IN STAPHYLOCOCCUS-AUREUS J2870 [J].
HODGSON, JE ;
CURNOCK, SP ;
DYKE, KGH ;
MORRIS, R ;
SYLVESTER, DR ;
GROSS, MS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) :1205-1208
[10]   In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis [J].
Hurdle, JG ;
O'Neill, AJ ;
Mody, L ;
Chopra, I ;
Bradley, SF .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (06) :1166-1168